Cytiva podcast highlights decision confidence as key bottleneck in biopharma development

In a recent episode of the Denatured podcast, hosted by BioSpace Insights director Jennifer Smith-Parker, the conversation focused on the challenges facing biopharma companies. The guest, Nicolas Pivet, who leads manufacturing and digital solutions at Cytiva, shared his perspective on the industry’s current hurdles.

The discussion emphasized that the primary obstacle is not a lack of data, but a shortage of confidence in the decisions that guide drug development, manufacturing, and commercialization. While firms have invested heavily in data collection and visibility, many still encounter delays and unexpected issues during scale‑up.

Pivet argued that building stronger decision confidence across the product lifecycle is essential to avoid these setbacks. He suggested that improving the way data is interpreted and applied could help streamline progress from the lab to the market.

The episode concludes with a disclaimer that the opinions expressed belong to the participants and do not reflect the official stance of their organizations.